Tumor Immunology is an interdisciplinary branch of biology that is concerned with understanding the role of the immune system in the progression and development of cancer; the most well-known application is cancer immunotherapy, which utilises the immune system as a treatment for cancer. Cancer immunosurveillance and immunoediting are based on protection against development of tumors in animal systems and (ii) identification of targets for immune recognition of human cancer. In the present book, fifteen typical literatures about Tumor Immunology published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on Tumor Immunology. We hope this book can demonstrate advances in Tumor Immunology as well as give references to the researchers, students and other related people.
Components of the Book:
- Chapter1
AllergoOncology: Opposite Outcomes of Immune Tolerance in Allergy and Cancer
- Chapter2
Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine
- Chapter3
AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer—a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)
- Chapter4
The Cholesterol Transporter ABCG1 Links Cholesterol Homeostasis and Tumor Immunity
- Chapter5
Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity
- Chapter6
Differential MyD88/IRAK4 requirements for cross-priming and tumor rejection induced by heat shock protein 70-model antigen fusion protein
- Chapter7
Understanding the tumor immune microenvironment (TIME) for effective therapy
- Chapter8
Immune Adjuvant Efficacy of CpG Oligonucleotide in Cancer Treatment Is Founded Specifically upon TLR9 Function in Plasmacytoid Dendritic Cells
- Chapter9
The Yin and Yang of Protein Kinase C-theta (PKCθ): A Novel Drug Target for Selective Immunosuppression
- Chapter10
TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy
- Chapter11
Tumor Necrosis Factor Receptor/Tumor Necrosis Factor Family Members in Antiviral CD8 T-Cell Immunity
- Chapter12
In vivo Imaging of Tumor and Immune Cell Interactions in the Lung
- Chapter13
The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity
- Chapter14
Leveraging premalignant biology for immune-based cancer prevention
- Chapter15
Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy
Readership:
Students, academics, teachers and other people attending or interested in Advances in Tumor Immunology.
E Jensen-Jarolim
The interuniversity Messerli Research Inst., University of Veterinary Medicine Vienna, Medical University Vienna, University Vienna, Austria
HJ Bax
St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, Guy’s Hospital, London, UK
TR Daniels-Wells
Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
E Fiebiger
Dept. Medicine Research, Div. of Gastroenterology, Hepatology and Nutrition Research, Children’s′ University Hospital Boston, Boston, MA
J Janda
Faculty of Science, Charles University, Prague, Czech Republic
and more...